Hyperphosphatemia
📧 Sign up to get email alerts when something new happens for Hyperphosphatemia.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-06-01FDA Approved: CALCIUM ACETATE — Original Application (Chartwell RX, LLC.)
FDA approved the original application for calcium acetate (Calcium Acetate) by Chartwell RX, LLC as a generic drug.
-
CLINICAL_TRIALS trial_result · 2012-01-18Clinical Trial Update: Nicotinamide in Hemodialysis Patients With Hyperphosphatemia [Phase 2]
A Phase 2 clinical trial evaluating nicotinamide for hyperphosphatemia in patients on hemodialysis has completed.
-
CLINICAL_TRIALS trial_result · 2011-11-15Clinical Trial Update: PD Study to Assess Phosphate Binding Characteristics of K2CG Chewing Gum [NA]
A completed clinical trial evaluating the pharmacodynamic phosphate-binding properties of K2CG Chewing Gum for hyperphosphatemia in chronic …
-
CLINICAL_TRIALS trial_result · 2011-11-15Clinical Trial Update: A Phase III, Multi-Centre, Randomised, Placebo-Controlled Study in Combination With Ca-based P Binders in Patients With Hyperphosphatemia [Phase 3]
A Phase III, randomized trial evaluating combination therapy with calcium-based phosphate binders for hyperphosphatemia in chronic kidney di…
-
FDA approval · 2011-09-02FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Fosrenol (lanthanum carbonate) submitted by Takeda Pharmaceuticals America, Inc.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA label_change · 2011-06-16FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for sevelamer carbonate (Renvela) submitted by Sanofi-Aventis U.S. LLC to update the product labelin…
-
FDA approval · 2011-06-16FDA Approved: SEVELAMER HYDROCHLORIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for sevelamer hydrochloride (Sanofi-Aventis U.S. LLC).
-
FDA approval · 2011-06-16FDA Approved: SEVELAMER CARBONATE — Supplemental Application (Sanofi-Aventis U.S. LLC)
The FDA approved a supplemental application for sevelamer carbonate (Renvela) submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2011-06-15Clinical Trial Update: Long-term Effect of Lanthanum Carbonate on Bone
A completed clinical trial assessing the long-term effects of lanthanum carbonate on bone health in patients with hyperphosphatemia; results…
-
CLINICAL_TRIALS research · 2011-04-18Clinical Trial Update: The Effect of Systemic Dietary Instruction on Management of Plasma Phosphorus Levels in Peritoneal Dialysis (PD) Patients [NA]
This entry notes a clinical trial update evaluating whether systemic dietary instruction can help manage plasma phosphorus levels in periton…
-
CLINICAL_TRIALS trial_result · 2011-03-22Clinical Trial Update: A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis [Phase 2]
Phase 2 study of ASP1585 in chronic kidney disease patients with hyperphosphatemia on hemodialysis completed.
-
CLINICAL_TRIALS trial_result · 2011-01-07Clinical Trial Update: Double Blind Randomized Placebo Controlled Trial of FOSTRAP Chewing Gum in Patients With CKD and Hyperphosphatemia [Phase 1]
A Phase 1 double-blind, randomized, placebo-controlled trial evaluating FOSTRAP chewing gum in patients with chronic kidney disease and hype…
-
CLINICAL_TRIALS research · 2010-11-22Clinical Trial Update: The Influence of Dietary Phosphorus Education Program on Nutritional Status and Serum Phosphate Level Among Hemodialysis Patient [NA]
Clinical trial evaluating whether a dietary phosphorus education program improves nutritional status and serum phosphate in hemodialysis pat…
-
FDA approval · 2009-08-12FDA Approved: SEVELAMER CARBONATE — Original Application (Sanofi-Aventis U.S. LLC)
FDA approved Sevelamer carbonate (brand Renvela) via an original NDA to treat hyperphosphatemia in adults with chronic kidney disease on dia…
-
CLINICAL_TRIALS trial_result · 2009-04-01Clinical Trial Update: Phosphorus Improvement Pilot Study [NA]
A clinical trial update indicates the Phosphorus Improvement Pilot Study for hyperphosphatemia has completed.
-
CLINICAL_TRIALS trial_result · 2009-02-09Clinical Trial Update: Bioequivalence Study Comparing Calcium Acetate Oral Solution Versus Calcium Acetate Gelcaps in Healthy Volunteers [Phase 1]
Phase 1 bioequivalence study comparing calcium acetate oral solution to calcium acetate gelcaps in healthy volunteers. The trial aims to est…
-
CLINICAL_TRIALS trial_result · 2009-01-16Clinical Trial Update: The Effect of Oral Niacinamide on Serum Phosphorus Levels in Hemodialysis Patients [Phase 1]
Phase 1 trial evaluating whether oral niacinamide lowers serum phosphorus in hemodialysis patients; the study has completed.
-
FDA approval · 2008-10-23FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for FOSRENOL (lanthanum carbonate) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2008-10-02FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Fosrenol (lanthanum carbonate) submitted by Takeda Pharmaceuticals America, Inc.
-
FDA approval · 2008-04-10FDA Approved: FOSRENOL — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for FOSRENOL (lanthanum carbonate) from Takeda Pharmaceuticals America, resulting in an approved lab…
-
FDA approval · 2008-02-26FDA Approved: CALCIUM ACETATE — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved Hikma Pharmaceuticals USA Inc.'s calcium acetate for use as a phosphate binder in patients with hyperphosphatemia due to chroni…
-
CLINICAL_TRIALS trial_result · 2008-01-08Clinical Trial Update: EPIC(Effect of PhosLo on Phosphorus Levels in Chronic Kidney Disease) [Phase 3]
Phase 3 trial update evaluating PhosLo for controlling phosphorus levels in chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2007-11-08Clinical Trial Update: Klotho Gene Polymorphism in Dialyzed Patients With Hyperphosphatemia
A clinical trial evaluating klotho gene polymorphism in dialysis patients with hyperphosphatemia has been terminated.
-
FDA approval · 2007-10-19FDA Approved: SEVELAMER CARBONATE — Original Application (Sanofi-Aventis U.S. LLC)
FDA approved SEVELAMER CARBONATE (Sanofi-Aventis U.S. LLC) for control of serum phosphate in adults with chronic kidney disease on dialysis.
-
FDA approval · 2007-08-14FDA Approved: SEVELAMER HYDROCHLORIDE — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for Sevelamer hydrochloride (Renagel) filed by Sanofi-Aventis U.S. LLC.